Earnings Preannouncement for 2025
Filed with SSE · · 2 pages · Chinese
Shanghai Shen Lian Biomedical Corporation on 6ix
Earlier from Shanghai Shen Lian Biomedical
- Announcement on Renewing Engagement of Accounting Firm
- Indicative Announcement on Termination of Shareholders’ Acting-in-Concert Relationship and the Change Reaching an Integer Multiple of 5%
- Indicative Announcement on Equity Change of Shareholder with Over 5% Shares Reaching an Integral Multiple of 5%
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on the Capital Increase and Share Expansion of an Associate Company to Introduce Strategic Investors, and on the Company’s Proposed Acquisition of Controlling Stake in the Associate Company and Signing of the Acquisition Framework Agreement and Related Party Transaction
Later from Shanghai Shen Lian Biomedical
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Equity Change of Shareholder with Over 5% Shares Reaching 1% Scale, Completion of Shareholding Reduction Plan and Results of Shares Sold
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Shanghai Shen Lian Biomedical into a list and get an email when it puts out news.
Follow Shanghai Shen Lian Biomedical